Filters close
Newswise: Combining Targeted Therapy and Immunotherapy Improves Overall Survival in Patients with Anaplastic Thyroid Cancer
24-Oct-2024 11:00 AM EDT
Combining Targeted Therapy and Immunotherapy Improves Overall Survival in Patients with Anaplastic Thyroid Cancer
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted therapy extended overall survival (OS) in patients with anaplastic thyroid carcinoma (ATC).

Newswise: UCLA Researchers Engineer Experimental Drug for Preventing Heart Failure After Heart Attacks
23-Oct-2024 11:15 AM EDT
UCLA Researchers Engineer Experimental Drug for Preventing Heart Failure After Heart Attacks
University of California, Los Angeles (UCLA), Health Sciences

An experimental therapeutic monoclonal antibody therapy could become the first to directly enhance tissue repair in the heart following a heart attack.

Released: 24-Oct-2024 10:40 AM EDT
Opioids May Negatively Impact Hormone Health
Endocrine Society

A new Scientific Statement released today by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system.

Newswise: Mitchell Weiss of St. Jude Children’s Research Hospital elected to the National Academy of Medicine
Released: 24-Oct-2024 10:00 AM EDT
Mitchell Weiss of St. Jude Children’s Research Hospital elected to the National Academy of Medicine
St. Jude Children's Research Hospital

Leading expert in catastrophic blood disorders becomes the seventh St. Jude faculty member tapped for this honor.

Newswise: Innovative Bioelectronic Device Offers New Hope in the Fight Against Bacterial Infections
Released: 24-Oct-2024 10:00 AM EDT
Innovative Bioelectronic Device Offers New Hope in the Fight Against Bacterial Infections
University of California San Diego

Researchers have developed a bioelectronic device that taps into the natural electrical activity of certain bacteria found on our skin, paving the way for a drug-free approach to managing infections. The advancement reduces the harmful effects of a bacterium known for antibiotic resistance.

Released: 24-Oct-2024 9:55 AM EDT
New Advances in Prostate Cancer Diagnosis: Outcomes from the 2022 Panjiayuan Consensus Conference
Chinese Academy of Sciences

The 2022 Panjiayuan Consensus Conference, held by the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences, has introduced pivotal advancements in prostate targeted biopsy (TB) strategies and development, marking a significant leap forward in the diagnosis and management of prostate cancer (PCa).

Newswise: RPI Appoints Dena Beard Executive Director of Curtis. R. Priem Experimental Media and Performing Arts Center
Released: 24-Oct-2024 9:35 AM EDT
RPI Appoints Dena Beard Executive Director of Curtis. R. Priem Experimental Media and Performing Arts Center
Rensselaer Polytechnic Institute (RPI)

Rensselaer Polytechnic Institute (RPI) has named Dena Beard, M.A., the new Executive Director of the Curtis R. Priem Experimental Media and Performing Arts Center (EMPAC).

Newswise: SMU Solution May Be to Low-Cost, Long-Lasting Renewable Batteries for Electric Vehicles
Released: 24-Oct-2024 9:20 AM EDT
SMU Solution May Be to Low-Cost, Long-Lasting Renewable Batteries for Electric Vehicles
Southern Methodist University

Lithium-sulfur batteries have never lived up to their potential as the next generation of renewable batteries for electric vehicles and other devices. But ​SMU mechanical engineer Donghai Wang and his research team have found a way to make these Li-S batteries last longer – with higher energy levels – than existing renewable batteries. The research team has been able to prevent Li-S batteries from producing an unwanted side effect known as polysulfide dissolution that appears over time, shortening their lifespan.

Released: 24-Oct-2024 9:10 AM EDT
Intrinsic Therapeutics Announces New Category 1 CPT Code for Bone Anchored Annular Closure, including the Barricaid® Annular Closure Device, to Treat Patients Undergoing Lumbar Discectomy for Herniated Discs
Intrinsic Therapeutics, Inc.

Intrinsic Therapeutics, Inc., a medical device company focused on preventing reherniation and reoperation following lumbar discectomy to treat herniated discs, announced today that the American Medical Association (AMA) CPT Editorial Panel has accepted the addition of a new Category 1 CPT Code for bone anchored annular closure. This is the first CPT Code to describe closing large annular defects using the Barricaid® device. The procedure is routinely performed by Orthopaedic Spine and Neurosurgeons.

Newswise: New JNCCN Study Suggests Medicaid Expansion Improves Cancer Care and Survival for People with Aggressive Type of  Breast Cancer
22-Oct-2024 11:35 AM EDT
New JNCCN Study Suggests Medicaid Expansion Improves Cancer Care and Survival for People with Aggressive Type of Breast Cancer
National Comprehensive Cancer Network® (NCCN®)

New study in JNCCN-Journal of the National Comprehensive Cancer Network that finds that people diagnosed with an aggressive breast cancer subtype (HR-negative, HER2-positive) are more likely to live longer in states that participate in Medicaid expansion under the Affordable Care Act (ACA).

21-Oct-2024 9:00 AM EDT
Study Finds Intense Exercise May Suppress Appetite in Healthy Humans
Endocrine Society

A vigorous workout does more to suppress hunger levels in healthy adults than does moderate exercise, and females may be especially susceptible to this response, according to a small study published in the Journal of the Endocrine Society.

Released: 24-Oct-2024 8:10 AM EDT
Stopping Surprise Ambulance Bills a Tough Policy Puzzle
Ohio State University

Figuring out how to protect Americans from surprise, expensive out-of-network emergency ambulance bills is a complicated task, new research from The Ohio State University shows. A study examining a New York law aimed at preventing these unexpected, often unavoidable bills found that ground ambulance providers raised their prices in response, a move likely to hit health consumers’ bank accounts through elevated insurance premiums.

Newswise: navbar-logo.png
18-Oct-2024 8:00 AM EDT
La Eliminación Del Etiquetado De La Alergia a La Penicilina en Pacientes Con Sífilis Ayuda a Avanzar en El Tratamiento
American College of Allergy, Asthma and Immunology (ACAAI)

Alrededor del 10% de los estadounidenses creen que son alérgicos a la penicilina, y aproximadamente el 90% de esos pacientes en realidad no son alérgicos.

Newswise: navbar-logo.png
18-Oct-2024 8:00 AM EDT
Aumenta La Necesidad De Derivaciones Psicológicas Para Niños Con Alergias Alimentarias
American College of Allergy, Asthma and Immunology (ACAAI)

Con el aumento de la incidencia de alergias alimentarias en los niños en la última década, ha habido un aumento correspondiente en la necesidad de servicios de psicología profesional debido al aumento de la ansiedad. Un nuevo estudio que se presentará en la Reunión Científica Anual del Colegio Americano de Alergia, Asma e Inmunología (ACAAI) de este año en Boston mostró un aumento de más del 50% en las derivaciones a psicólogos en un centro en 2023 en comparación con las derivaciones anuales de 2018 a 2022.



close
5.11511